BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7803299)

  • 1. PML-RAR alpha PCR positivity in the bone marrow of patients with APL precedes haematological relapse by 2-3 months.
    Korninger L; Knöbl P; Laczika K; Mustafa S; Quehenberger P; Schwarzinger I; Lechner K; Jaeger U; Mannhalter C
    Br J Haematol; 1994 Oct; 88(2):427-31. PubMed ID: 7803299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation.
    Perego RA; Marenco P; Bianchi C; Cairoli R; Urbano M; Nosari AM; Muti G; Morra E; Del Monte U
    Leukemia; 1996 Feb; 10(2):207-12. PubMed ID: 8637228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
    Grimwade D; Howe K; Langabeer S; Burnett A; Goldstone A; Solomon E
    Leukemia; 1996 Jan; 10(1):61-6. PubMed ID: 8558940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA.
    Miller WH; Levine K; DeBlasio A; Frankel SR; Dmitrovsky E; Warrell RP
    Blood; 1993 Sep; 82(6):1689-94. PubMed ID: 8400225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse.
    Huang W; Sun GL; Li XS; Cao Q; Lu Y; Jiang GS; Zhang FQ; Chai JR; Wang ZY; Waxman S
    Blood; 1993 Aug; 82(4):1264-9. PubMed ID: 8394752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of minimal residual disease in a patient with acute promyelocytic leukemia by RT-PCR: necessity of chemotherapy following ATRA therapy.
    Sun T; Takatsuki H; Yamashita S; Yufu Y; Umemura T; Nishimura J; Nawata H
    Fukuoka Igaku Zasshi; 1994 Feb; 85(2):52-6. PubMed ID: 8144129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia.
    Koller E; Karlic H; Krieger O; Mistrik M; Michlmayr G; Gadner H; Lutz D; Heinz R; Pittermann E
    Ann Hematol; 1995 Feb; 70(2):75-8. PubMed ID: 7880927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged molecular remission after PML/RAR alpha-positive autologous peripheral blood stem cell transplantation in acute promyelocytic leukemia: is relevant pretransplant minimal residual disease in the graft?
    Sanz MA; de la Rubia J; Bonanad S; Barragán E; Sempere A; Martín G; Martínez JA; Jiménez C; Cervera J; Bolufer P; Sanz GF
    Leukemia; 1998 Jun; 12(6):992-5. PubMed ID: 9639431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. The Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho).
    Fukutani H; Naoe T; Ohno R; Yoshida H; Kiyoi H; Miyawaki S; Morishita H; Sano F; Kamibayashi H; Matsue K
    Leukemia; 1995 Apr; 9(4):588-93. PubMed ID: 7723389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study.
    Laczika K; Mitterbauer G; Korninger L; Knöbl P; Schwarzinger I; Kapiotis S; Haas OA; Kyrle PA; Pont J; Oehler L
    Leukemia; 1994 Jan; 8(1):1-5. PubMed ID: 8289472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3.
    Virchis A; Massey E; Butler T; Devaraj P; Wright F; Secker-Walker L; Prentice HG; Mehta A
    Br J Haematol; 2001 Sep; 114(3):551-6. PubMed ID: 11552979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia.
    Kane JR; Head DR; Balazs L; Hulshof MG; Motroni TA; Raimondi SC; Carroll AJ; Behm FG; Krance RA; Shurtleff SA; Downing JR
    Leukemia; 1996 Aug; 10(8):1296-302. PubMed ID: 8709634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute promyelocytic leukaemia and the t(15;17) translocation.
    Gillard EF; Solomon E
    Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
    Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
    Park TS; Lee ST; Kim JS; Song J; Lee KA; Kim SJ; Seok YM; Lee HJ; Han JH; Kim JK; Lee EY; Choi JR
    Cancer Genet Cytogenet; 2009 Jan; 188(1):48-51. PubMed ID: 19061780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
    Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
    Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.